Qube Research & Technologies (QRT)’s Voyager Therapeutics VYGR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$679K	Buy	194,049 +176,544	+1,009%	+$670K	﹤0.01%	2551
2026 Q1	$67.6K	Buy	+17,505	New	+$68.9K	﹤0.01%	3127
2024 Q2	–	Sell	-7,413	Closed	-$69K	–	4806
2024 Q1	$69K	Sell	7,413 -26,750	-78%	-$226K	﹤0.01%	3420
2023 Q4	$288K	Sell	34,163 -63,920	-65%	-$464K	﹤0.01%	2604
2023 Q3	$760K	Buy	+98,083	New	+$896K	﹤0.01%	1851
2023 Q2	–	Sell	-82,326	Closed	-$635K	–	3084
2023 Q1	$635K	Buy	82,326 +52,504	+176%	+$418K	﹤0.01%	1470
2022 Q4	$182K	Buy	29,822 +4,659	+19%	+$26.5K	﹤0.01%	1850
2022 Q3	$149K	Buy	25,163 +6,544	+35%	+$41.9K	﹤0.01%	1857
2022 Q2	$110K	Buy	+18,619	New	+$126K	﹤0.01%	1913

Other funds holding VYGR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VYGR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Voyager Therapeutics (VYGR) stake by 1,009% in Q2 2026, buying an estimated $670K and bringing the position to 194,049 shares worth $679K. The position accounts for ﹤0.01% of the portfolio, ranked #2551.

Qube Research & Technologies (QRT) first reported a position in VYGR in Q2 2022 and has held it in 9 quarters since. The position peaked at $760K in Q3 2023. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

Qube Research & Technologies (QRT) held 194,049 shares of Voyager Therapeutics worth $679K as of Q2 2026.
Qube Research & Technologies (QRT) bought 176,544 Voyager Therapeutics shares in Q2 2026, an estimated $670K.
Voyager Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2551 holding.
Qube Research & Technologies (QRT) first reported a position in Voyager Therapeutics in Q2 2022 and has held it in 9 quarters since.
Qube Research & Technologies (QRT)'s Voyager Therapeutics position peaked at $760K in Q3 2023.
136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.